Related Articles
Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review)
Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells.
The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway
Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo
Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells